- Barrons.com
Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2
Automated pumps are already used by about 40% of those with the autoimmune version of diabetes, known as Type-1. Insulet is aiming at the shallowly penetrated market of patients with Type-2.Read the full ...
- Zacks
ESLOY vs. PODD: Which Stock Is the Better Value Option?
ESLOY vs. PODD: Which Stock Is the Better Value Option?
- Bloomberg
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
(Bloomberg) -- The new class of weight-loss drugs being tested as cure-alls for everything from knee replacements to liver disease keeps throwing corners of the stock market into disarray.Most Read from BloombergNvidia’s 13% Stock Rout Has Traders Scouring Charts for SupportBuzzFeed Struggles to Sell Owner of Hit YouTube Show ‘Hot Ones’Jain Global Raises $5.3 Billion, Secures Cash From Abu DhabiHow Long Can High Rates Last? Bond Markets Say Maybe ForeverWikileaks’ Julian Assange to Plead Guilty,
